BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21573485)

  • 21. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
    Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
    Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
    Schölzel C; Löwenberg B
    Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
    Bühring HJ; Herbst R; Kostka G; Bossenmaier B; Bartke I; Kropshofer H; Kalbacher H; Busch FW; Müller CA; Schlessinger J
    Cancer Res; 1993 Sep; 53(18):4424-31. PubMed ID: 7689935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia.
    Wang YF; Kelleher CA; Minkin S; McCulloch EA
    Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
    Matsumura I; Ikeda H; Kanakura Y
    Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: association with reduced growth capacity.
    Wang C; Kelleher CA; Cheng GY; Miyauchi J; Wong GG; Clark SC; Minden MD; McCulloch EA
    J Cell Physiol; 1988 Apr; 135(1):133-8. PubMed ID: 3259234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternate splicing creates two forms of the human kit protein.
    Zhu WM; Dong WF; Minden M
    Leuk Lymphoma; 1994 Feb; 12(5-6):441-7. PubMed ID: 7514064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia.
    Cole SR; Aylett GW; Harvey NL; Cambareri AC; Ashman LK
    Leukemia; 1996 Feb; 10(2):288-96. PubMed ID: 8637238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically determined regulators acting on the blast cells of acute myeloblastic leukemia.
    McCulloch EA; Minden MD; Kelleher C; Miyauchi J; Wang C; Cheng GY
    Acta Haematol; 1987; 78 Suppl 1():18-25. PubMed ID: 2829486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nobiletin Down-Regulates c-KIT Gene Expression and Exerts Antileukemic Effects on Human Acute Myeloid Leukemia Cells.
    Chen PY; Chen YT; Gao WY; Wu MJ; Yen JH
    J Agric Food Chem; 2018 Dec; 66(51):13423-13434. PubMed ID: 30507186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-9 in human myeloid leukemia cells.
    Lemoli RM; Fortuna A; Tafuri A; Grande A; Amabile M; Martinelli G; Ferrari S; Tura S
    Leuk Lymphoma; 1997 Aug; 26(5-6):563-73. PubMed ID: 9389363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
    Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
    Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Steel factor].
    Cáceres-Cortés JR
    Rev Invest Clin; 1997; 49(6):507-14. PubMed ID: 9528312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer.
    Parrott JA; Kim G; Skinner MK
    Biol Reprod; 2000 Jun; 62(6):1600-9. PubMed ID: 10819761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
    Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
    Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity in acute myeloblastic leukemia.
    McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
    Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of recombinant human M-CSF on the proliferation of leukemic blast progenitors in AML patients.
    Suzuki T; Nagata K; Murohashi I; Nara N
    Leukemia; 1988 Jun; 2(6):358-62. PubMed ID: 3287022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.